Today’s Neurology Science Briefing
A recent BMJ Neurology brief highlights robust evidence that subthalamic deep brain stimulation (DBS) offers measurable motor benefits for patients with symmetric Parkinson's disease, giving clinicians clearer risk‑benefit guidance. The study’s real‑world data strengthens counseling on DBS candidacy and expected outcomes. In parallel, researchers reported engineering CAR T cells to express the glucose transporter GLUT3, a novel approach aimed at enhancing cerebral glucose uptake. Both advances signal a shift toward more precise, metabolism‑focused neurotherapeutics.
Today’s Public Health Science Briefing
Recent research published in The Lancet Diabetes & Endocrinology finds that men with diabetes who maintain low levels of visceral fat face a markedly lower risk of developing diabetic kidney disease. The study highlights that relying solely on Body Mass...
The Artemis II Launch: A Global Milestone and a Mirror for China’s Ambitions
In early April 2026 NASA launched Artemis II, its most powerful rocket carrying four astronauts on a ten‑day lunar orbit mission, the first crewed Moon flight since 1972. The flight serves as a critical test for the Orion capsule, the Space...